Drug
D2C7-IT
D2C7-IT is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Recruiting3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
recruiting375%
completed125%
Recent Activity
3 active trials
Showing 4 of 4
completedphase_1
D2C7 for Adult Patients With Recurrent Malignant Glioma
NCT02303678
recruitingphase_1
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
NCT06455605
recruitingphase_1
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
NCT05734560
recruitingphase_1
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
NCT04547777
Clinical Trials (4)
Showing 4 of 4 trials
NCT02303678Phase 1
D2C7 for Adult Patients With Recurrent Malignant Glioma
NCT06455605Phase 1
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
NCT05734560Phase 1
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
NCT04547777Phase 1
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4